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1. Introduction
Viruses are a vastly diverse group of infectious particles with many different structures,
mechanisms of function and ingenious strategies of invading host organisms for their own
proliferation. One of the key features that ties viruses together as an inclusive group, is the
reliance on living cells for replication and propagation. On their own, viruses lack the cellular
machinery necessary for many life-sustaining functions including protein translation and
metabolism. Regardless of the organization of a viral genome or the type of nucleic acid,
infection of a host cell and viral propagation is dependent on the transcription of viral mRNA
and, in turn, the translation of viral proteins as well as genome replication. Because viruses
are dependent on host cell machinery for most of these processes, they have driven an
outstanding virus-host co-evolution. Viruses that rely on the replication machinery of the host
cell become cell-cycle dependent in their own replication. Furthermore, just as viruses have
evolved ways to hijack necessary cellular proteins, cells have evolved complex mechanisms
for fighting infection by detection and degradation of foreign mRNA. In order for viral mRNA
to utilize host cell machinery, begin translation and remain both stable and undetected in the
cytoplasm, it must contain the post-translational modifications of a host cell mRNA including,
but not limited to, a 5’ cap structure. By disguising viral mRNA with the same structural
elements found in host mRNA, the cellular defense mechanism can be evaded and protein
translation may occur. The significance of the cap structure can be seen through the diversity
of cap-synthesis pathways across vastly different viral families that all lead to the formation
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of a ubiquitous RNA 5’-cap. The 5’→ 3’ direction of nucleotide triphosphate (NTP) polymeri‐
zation during RNA synthesis creates a nascent mRNA molecule with a 5’-triphosphate moiety
resulting from the initial NTP on the 5’-end. Through the processes involved in cap synthesis,
the pppRNA structure is transformed into a basic, cap-0 RNA structure (m7GpppN). Further
2'-O-methylations of the first and second nucleotides of the RNA may occur.
In this chapter, a number of processes used by viruses to synthesize, acquire or mimic a 5’ cap
are explored to highlight the similarities and differences in the enzymatic mechanisms that
lead to the maturation of a 5’cap on viral RNA and its importance in viral genome replication
within a host cell.
2. Description of the RNA cap structure
To understand the importance of an RNA cap structure for viruses, it is crucial to first
understand why this structure is essential to their eukaryotic hosts. Prokaryotic RNA tran‐
scription and protein translation are coupled due to the spatial proximity between DNA and
ribosomes. In eukaryotic cells however, newly synthesized RNA transcripts undergo several
nuclear post-transcriptional modifications, known as RNA processing, before they are
exported and translated in the cytoplasm. These eukaryotic pre-mRNA modifications include
the addition of a cap structure at the 5’-end, the splicing out of introns, the editing of nucleo‐
bases and the addition of a poly(A) tail at the 3’-end. RNA capping is a co-transcriptional
process that occurs when an RNA molecule is 20-30 nucleotides in length. The cap structure
consists of a guanosine residue, harboring a methylation in the N-7 position, which is bound
to the terminal 5’-end nucleotide with a peculiar 5’-5’ triphosphate bridge (Fig. 1). This inverted
link between the two nucleotides prevents RNA degradation by 5’-3’ exonucleases. The second
important feature of the cap structure is the presence of the methyl group on the guanosine,
which confers a positive charge that plays an important role in its specific recognition by
specialized proteins. The cap structure fulfills many roles which ultimately lead to mRNA
translation. In the nucleus for instance, the cap structure of pre-mRNAs is recognized by the
cap binding proteins (CBP20 and CBP80). This cap binding complex (CBC) protects mRNA
from degradation and assists RNA transport from the nucleus to the cytoplasm. Once in the
cytoplasm, ribosomes and translation factors must be recruited for translation of mRNAs into
proteins. The eukaryotic translation initiation factor 4E (eIF4E) specifically binds to the RNA
cap structure [1]. This association is mediated through stacking interactions between two
aromatic residues of the eIF4E protein; the mRNA binding is further stabilized by specific
hydrogen bonds between the positive charge of the 7-methylguanosine and an acidic residue
[2]. Upon cap binding, eIF4E assembles with eIF4G (a scaffold protein) and eIF4A (an RNA
helicase) into the eIF4F complex [3]. The scaffolding protein eIF4G recruits the small 40S
ribosomal subunit through the eIF3 complex [4]. The translation initiation complex then scans
the mRNA for the start codon before recruiting the larger subunit of the ribosome, and
translation of the open reading frame (ORF) takes place [2]. Taken together, the roles fulfilled
by the RNA cap structure are crucial for RNA stability and translation. Because of this, many
Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications28
eukaryotic viruses require strategies, such as RNA cap synthesis, in order to protect, replicate
and translate their genomes in eukaryotic hosts.
Figure 1. RNA 5’-cap structure. The RNA 5’cap structure is composed of a 7-methylguanosine (blue) linked to the
RNA (black) through a 5’-5’ triphosphate bridge (blue and black). The N7 methylation of the guanosine (green) con‐
fers a positive charge to the cap structure. Additional 2’O-methylation (red) can be found on the first few nucleotides.
3. Conventional and unconventional 5’ RNA cap synthesis mechanism
3.1. Canonical cap synthesis by different viruses
The importance of the cap structure in eukaryote metabolism has resulted in an evolutionary
pressure for viruses to adopt a similar cap structure. A series of enzymatic reactions is required
to synthesize a cap structure at the 5’-end of RNA. The most pervasive enzymatic pathway,
also termed “conventional capping”, consists of three sequential enzymatic activities that are
required to generate a functional 7-methylguanosine 5’-5’-triphosphate bridged cap structure.
As a result of the directional 5’ to 3’ polymerization of nucleotide triphosphates (NTP) during
RNA synthesis, nascent RNA bear at their 5’-end a triphosphate moiety (originating from the
initial NTP). This 5’-triphosphate end of the RNA is first converted into a 5’-diphosphate end
by hydrolysis of the terminal phosphate, or γ-phosphate, by an RNA triphosphatase (RTPase).
This is followed by a two-step reaction catalyzed by an RNA guanylyltransferase (GTase). The
enzyme first specifically binds and hydrolyzes a GTP molecule to form a covalent enzyme-
GMP intermediate, which then catalyzes the transfer of the GMP moiety onto the 5’-end of a
diphosphorylated acceptor RNA (ppRNA) in the second step of GTase reaction. Lastly, an
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RNA (guanine-N-7)-methyltransferase (N7MTase) uses S-Adenosyl methionine (SAM) as a
methyl group donor in order to methylate the guanosine residue of the cap structure at the N7
position. This sequence of enzymatic modifications yields the minimal RNA cap-0 structure
(m7GpppN). Subsequent methylation of the 2’-hydroxyl group of the first few nucleotides of
the RNA can be catalyzed by a (nucleoside-2’-O)-methyltransferase (2’OMTase) again using a
SAM molecule as a methyl-donor (Fig. 2). Further methylations on the caps proximal nucleo‐
tides convert a cap-0 structure into a cap-1 (m7GpppNm) or cap-2 (m7GpppNmNm) structure.
Figure 2. Canonical 5’ RNA cap synthesis pathway. RNA cap-1 structures are conventionally synthesized by the se‐
quential γ-phosphate hydrolysis by an RTPase, GMP transfer by a GTase, N7-methylation by an N7MTase, and 2’O-
methylation by a 2’OMTase. The contribution of each substrate to the formation of the final 5’ RNA cap structure is
highlighted by a color code: pppRNA (black), GTP (blue) and SAM (green and red).
The conventional RNA 5’ cap synthesis mechanism is used by a majority of viruses in order
to acquire a cap structure. Most DNA viruses together with the RNA viruses from the
Bornaviridae and Retroviridae families use the host RNA polymerase II (RNA Pol II) to transcribe
their mRNAs. As a result, the majority of DNA virus transcripts are co-transcriptionally
capped using the cellular capping apparatus. Alternatively, many RNA viruses with a
cytoplasmic replication cycle, do not have access to the host RNA Pol II and therefore have
evolved their own capping machinery. Over time, a wide diversity of enzyme structures and
Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications30
mechanisms of action have evolved to generate the same highly conserved RNA cap structure
(Fig. 3). The following paragraphs describe the enzymes supporting the RTPase, GTase,
N7MTase and 2’OMTase activity.
Figure 3. Viral RNA 5’-end structure and maturation. Nearly all mammalian viruses modify their RNA 5’-end
through the covalent addition of a cap structure (majority) or a VPg protein (minority). Although the widely acquired
RNA cap structure is chemically identical (m7GpppN), viruses have evolved a large variety of mechanisms to synthesize
or acquire this crucial structure. The mechanisms of 5’-end maturation vary among order and families of viruses as
presented in the above schematic (for clarity, only a few viral families are presented). Within the Flaviviridae family, the
Flavivirus synthesize a typical cap structure while the Hepacivirus and Pestivirus are the only mammalian viruses repre‐
sentative to harbor an unmodified 5’-triphosphate end. Their RNA 5’ UTR instead folds into a highly structured three-
dimensional conformation termed IRES. Of notice, the Retroviridae RNA harbor both, a cap structure and an IRES, as
well as the Picornaviridae RNA that harbors both an IRES and a 5’-VPg-linked protein. Adapted from Decroly and al.
(2012).
3.2. RNA triphosphatases
The RTPase activity is the first of the three enzymatic reactions required to synthesize a cap
structure. The RTPase hydrolyzes the γ-β-phosphoanhydride bond at the 5’-end of an RNA
to yield an RNA 5’-diphosphate and inorganic phosphate (Pi). Viruses have evolved a wide
variety of enzyme structures and mechanisms of action to fulfill the RTPase activity, a greater
diversity than is seen with any other enzymatic capping activity. RTPases are classified as
either belonging to the metal-dependent family or the metal independent family based on their
cofactor requirements. As indicated by its name, the first family requires a divalent cation
cofactor for its activity. This metal requirement is usually satisfied by Mg2+, although Mn2+ is
also able to support the RTPase activity [5]. This family of enzymes also shares the ability to
hydrolyze free NTPs, again in the presence of a metal cofactor [5, 6]. The lack of substrate
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specificity is speculated to be a result of the chemical similarity between an NTP and the RNA
5’-triphosphate end. The metal dependent RTPase family is further subdivided into three
distinct structural groups, namely the triphosphate tunnel metalloenzyme (TTM), histidine
triad-like (HIT-like) and helicase-like RTPase (Fig. 4).
Figure 4. Diversity in RNA triphosphatase structure and mechanism of action. The RTPase activity can be cata‐
lyzed by various mechanisms of action, each associated with a characteristic structure. They are indicated as follows:
TTM (blue), HIT-like (multimeric: dark pink, monomeric: red), Helicase-like (cyan) and metal-independent (green). The
location of the active site is indicated by and arrow, and examples of hosts and viruses utilizing those enzymes are
given.
The TTM enzymes are found in chlorella virus, poxviruses, baculoviruses, mimiviruses and
lower eukaryotes. All TTM RTPases fold in a specific, characteristic structure. An assembly of
eight antiparallel β-strands to form a tunnel scaffold surrounding the active site (Fig. 4). The
interior of the tunnel is dominated by hydrophilic amino acid side chains oriented toward the
center of the tunnel creating a network of interactions for the triphosphate moiety of the
substrate [7]. Glutamate residues, within this amino acid network are also responsible for the
coordination of the crucial cation cofactor [6]. The recognition of the RNA substrate, primarily
through its triphosphate moiety, could explain the activity of the TTM RTPase against NTP
substrates. Interestingly, this NTP hydrolysis is not supported by Mg2+, but is rather dependent
on Mn2+ or Co2+ [6]. The coordinated metal ion, in conjunction with basic lysine and arginine,
activates the γ-phosphate and stabilizes the pentacoordinate phosphorane transition state. A
glutamate serves as a general base catalyst to activate the nucleophilic water for the attack on
the γ-phosphorus according to a one-step in-line mechanism [8]. TTM RTPases have been
acquired by large DNA viruses from their hosts [7]. Interestingly, modern Poxviridae infect
higher eukaryotes that lack TTM RTPase, underlying their evolution from viral ancestors that
replicated in unicellular eukarya, from which they likely acquired a TTM RTPase.
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The HIT-like RTPase is so far only represented by the NSP2 enzyme of rotaviruses (dsRNA
virus). The name of this family is based on the structural resemblance between the NSP2 C-
terminal domain (CTD) and the ubiquitous cellular histidine triad nucleotidyl hydrolases
(HIT). The NSP2 protein associates into an octamer to form a doughnut-shaped quaternary
structure (Fig. 4) [9, 10]. RNA binding grooves are found at the surface of the doughnut-shape
while the active site is buried deep in an electro-positive cleft on each monomer. Despite
structural similarity with HIT, NSP2 appears to be catalytically distinct. The catalytic histidine
triad requires a Mg2+ cofactor to hydrolyze the γ-β-phosphoanhydride and form a covalent
phosphate-histidine intermediate [11]. The enzyme harbours similar catalytic rates toward
both NTP and pppRNA substrates. Increased affinity for RNA, conferred by the RNA binding
grooves, is speculated to stimulate RTPase activity over NTPase activity in vivo [10]. Despite
the structural similarity with HIT, currently no evidence indicates that HIT-like RTPase could
have evolved from their cellular counterpart, and rather a convergent evolution is more
probable [9].
The helicase-like RTPases are found in a variety of ss(+) RNA viruses of the flavivirus,
coronavirus, potexvirus and alphavirus genera and the dsRNA viruses of the Reoviridae family.
These enzymes are active NTPase-helicases and belong to the large helicase superfamilies SF1
and SF2. The NTPase activity fuels the energy-consuming strand displacement of the helicase
activity. The common NTPase-RTPase catalytic site is located in a cleft formed from the
junction of two RecA-like subdomains (Fig. 4). As with many nucleotide-binding proteins, the
active site of helicase-like RTPases harbour both a Walker A and Walker B motif [12, 13]. The
Walker A motif (GxxxxGK(T/S)), or phosphate-binding loop (P-loop), is responsible for
contacting the γ-phosphate through its highly conserved arginine. The aspartate of the Walker
B motif (DExD) coordinates the crucial Mg2+, which stabilizes the γ and β-phosphates, while
the glutamate activates the water molecule for the hydrolysis reaction [14]. The addition of the
RTPase activity to an NTPase-helicase ancestor appears to result form only a minor evolu‐
tionary progression as the ancestor enzyme already displayed the key RTPase features,
namely, a nucleic acid binding domain, a triphosphate binding active site and a terminal
phosphate hydrolysis activity.
The second family of RTPases is the metal-independent group. Higher eukaryotic viruses that
rely on capping apparatus of the cell use the host metal-independent RTPase. Moreover,
baculovirus also expresses such a metal-independent RTPase. Two striking differences
between this enzyme family and the metal-dependent family, are its cation-independent
mechanism of action and its inability to hydrolyze free NTP [15]. Metal-independent RTPases
are members of the cysteine phosphatase superfamily, sharing their signature
HCxxxxxR(S/T) P-loop motif located in a deep positively charged pocket. The catalytic cysteine
is located at the bottom triphosphate binding cleft formed by the characteristic α/β-fold ternary
structure (Fig. 4) [15, 16]. The catalytic cycle fits a two-step phosphoryl-transfer reaction. First,
the pppRNA γ-phosphate is attacked by the catalytic cysteine to form a covalent protein-
cysteinyl-S-phosphate intermediate which results in the release of the ppRNA product. Next,
a water molecule attacks the phosphocysteine to expel the inorganic phosphate and regenerate
the enzyme [15]. The metal-independent RTPase presumably evolved from the cysteine
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phosphatase ubiquitously found in higher eukaryotes and was later acquired by baculovirus
from their hosts. Interestingly, baculovirus also encodes a second TTM RTPase fulfilling the
same role. This unconventional carrying of two distinct enzymes having the same activity is
speculated to be an evolutionary snapshot of an RTPase transition from the lower eukaryote
TTM RTPase to the higher eukaryote metal-independent RTPase.
3.3. RNA guanylyltransferase
The second step of the capping sequence is the GTase activity. GTase catalyzes the rate-limiting
transfer of a GMP moiety from a GTP substrate to an acceptor ppRNA to yield an unmethylated
cap structure (GpppN). GTases are members of the covalent nucleotidyltransferases super‐
family which also includes the ATP- and NAD+-dependent DNA ligases and the ATP-
dependent RNA ligases [17]. This superfamily’s ternary structure is composed of the N-
terminal of the nucleotidyltransferase (NT) domain fused to an oligobinding fold (OB-fold)
domain in the C-terminal. These flexible proteins are able to undergo large conformational
changes during their catalytic cycle. GTases share highly conserved structures and motifs, of
which the hallmark KxDG(I/L) motif is present in nearly all GTases [18]. The catalytic cycle of
the GTase is a complex two-step ping-pong reaction involving multiple conformational
changes. First, a GTase in a conformation where the OB-fold domain is distant from the NT
domain (open conformation) specifically binds a GTP molecule. This is followed by the closure
of the OB-fold domain toward the NT domain (closed conformation) which is stabilized by
interactions between the bound nucleotide and residues from both NT and OB fold domains.
This conformational change also creates a Mg2+ cofactor binding site, thus the closed confor‐
mation represents the catalytically active form of the enzyme [19, 20]. Upon Mg2+ binding, the
α-phosphate of the GTP is sandwiched between the catalytic lysine (form the KxDG) and the
metal cofactor. Deprotonation of the lysine leads to the attack on the α-phosphate of the GTP
to form a enzyme-(lysyl-N)-GMP intermediate (EpG), concomitant with the hydrolysis of a
pyrophosphate molecule [20]. Following the catalysis, interactions between the bound
guanylate and the OB fold domain are disrupted, leading to the reopening of the enzyme and
the release of pyrophosphate. The reopening of the guanylylated enzyme allows for accom‐
modation of the ppRNA, which is likely followed by the closure of the OB-fold domain. Closing
of the OB-fold domain returns the enzyme to its catalytically active form, which promotes the
transfer of the GMP to the acceptor RNA. A final reopening allows for unmethylated capped
RNA to be released and the apo-protein to be regenerated (Fig. 5) [19]. The active sites of the
GTase are highly conserved, potentially due to their fairly complex catalytic cycle. Most viruses
encode GTases that are, with respect to the active site, nearly identical to their eukaryotic host
GTase, favouring the hypothesis of ancestral viral acquisition of the host GTase.
While nearly all GTases are highly conserved, a few recently discovered viral GTases are
different. Little is currently known about those atypical GTases lacking the catalytic KxDG
motif. Some segmented dsRNA viruses of the Reoviridae family encode for a large multiprotein
capsid harbouring nucleic acid maturation functions, including GTase activity. The Reoviri‐
dae GTase is structurally different from the conventional GTase. While they lack the conserved
KxDG motif, they still maintain the capacity to form an enzyme-(lysyl-N)-GMP intermediate.
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The flavirivus GTases are also atypical. Their activities are found on the N-terminal portion of
the RDRP-MTase peptide. They are structurally distinct from both the conventional and the
Reoviridae GTase but they still mediate RNA guanylation through a two-step mechanism
involving an EpG intermediate [21, 22]. The precise amino acid involved in the guanylate-
enzyme complex formation is also speculated to be a lysine, but a histidine or an arginine
residue may also play this role. Progress in the field of atypical viral capping enzymes will
eventually shed light on those imprecisions.
3.4. RNA methyltransferase
The third step of the RNA 5’-end cap synthesis is the methylation of the cap guanosine by a
N7MTase. An N7MTase adds a methyl group to the guanine at the N7 position in order to
convert the GpppN into a functional m7GpppN cap-0 structure. The conversion of S-Adenosyl
Figure 5. Structural and mechanistic pathway used by GTase. The apo-enzyme in open conformation (blue) binds
a GTP substrate (gray), closes (red) and proceeds to hydrolysis thereby generating an enzyme-GMP (black) intermedi‐
ate. GTase reopening (blue) allows for RNA binding (orange), the enzyme either stays open or closed to allow GMP
transfer onto the RNA. Finally, the open enzyme releases the GpppN product and the apo-enzyme is regenerated.
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methionine (SAM) into S-Adenosyl homocysteine (SAH) provides the methyl group. N7MTas‐
es are members of the large SAM-dependent MTase family, which shares a low sequence
identity but a structurally conserved SAM binding core. This SAM binding pocket, composed
of a seven-stranded β-sheet flanked by six α-helices, ensures specific and proper positioning
of the SAM molecule, while other structural determinants provide specificity for a range of
methyl acceptors [23, 24]. For the N7MTase, those structural determinants are a positively
charged RNA-accommodating groove and a GpppN binding pocket that forms extensive
electrostatic interactions with the cap guanine, thereby ensuring specificity [25]. Despite a
broad network of interactions with both substrates (GpppN and SAM), no direct contact is
made between the N7MTase and their substrate reacting group: the guanine N7 nitrogen
(methyl acceptor) and the SAM CH3 (methyl donor). The methyl transfer is instead mediated
by a direct in-line nucleophilic attack of the SAM methyl moiety by the guanine N7 nitrogen.
N7MTases are not directly implicated in the transition state stabilization, but are rather
optimizing the proximity and the spatial orientation between both ligands reacting groups. In
addition, a favourable electrostatic environment further stimulates the catalysis [25]. The
degree of conservation among N7MTases is very high and most viral and eukaryotic N7MTas‐
es only differ in their accessory domain. A rare exception is the poxvirus N7MTase, which
appears to bind SAM in a slightly different conformation. Moreover, some poxviruses, such
as vaccinia virus, have evolved a heterodimer N7MTase. The vaccinia virus N7MTase D1 for
example relies on its association with the accessory protein D12 to be fully active [26]. The
degree of conservation among N7MTases points toward a common eukaryotic ancestor
acquired by viruses.
Lastly, some viruses infecting higher eukaryotes, such as flavirirux, reovirus and poxvirus, can
further modify their RNA 5’-end through 2’-O-methylation in order to more accurately mimic
their host mRNA modifications. This last modification is not required for viruses infecting
lower eukaryotes as their host harbours cap-0 mRNA. The 2’OMTase methylates the first
nucleotide 2’-hydroxyl group(s) of the RNA, allowing for the conversion of a m7GpppN (cap-0)
into a m7GpppNm (cap-1). The 2’OMTases are also members of the large SAM-dependent MTase
family. When compared to the N7MTase, 2’OMTase harbours an additional highly conserved
catalytic lysine-asparagine-lysine-glutamine tetrad [27]. These amino acids are not consecutive
in the primary sequence, but they cluster together once the protein adopts its three-dimen‐
sional structure. The exact catalytic pathway is still controversial, but relies on the conserved
asparagine and arginine to lower the pKa of the catalytic lysine, which is responsible for the
2’-hydroxyl group activation. Two mechanisms are proposed for this substrate activation. The
first involves the lysine deprotonating the 2’-OH to form a nucleophilic 2’-oxanion. The second
implicates the lysine in the formation of a non-deprotonating hydrogen bound with a 2’-
hydroxyl proton, which freezes the 2’-OH rotation in an angle where the 2’-oxygen electron
lone pair is steered toward the SAM methyl group. In both cases, the nucleophilic 2’-oxygen
attacks the electrophilic SAM methyl group according to an in-line Sn2 mechanism [28-31].
The pentavalent methyl intermediate of the transition state is stabilized by the asparagine.
Despite the structural homology with the N7MTase, the 2’OMTase harbours a distinct
mechanism of methyl transfer. Interestingly, some viruses, such as the flavivirus, have evolved
both N7MTase and 2’OMTase activities within the same enzyme [22, 32]. These dual MTases
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share the same SAM binding site and accessory domain but not the same mechanism of methyl
transfer. The classical N7MTase and 2’OMTase mechanisms are instead present but inde‐
pendent. It is, for example, possible to abolish the 2’OMTase activity through disruption of the
lysine-asparagine-lysine-glutamine tetrad while maintaining the N7MTase activity [22, 32]. It
is important to note that the flavivirus dual MTase accomplishes a sequential methylation,
starting with the N7 guanine methylation and followed by a repositioning of the cap structure
and finally, the 2’-hydroxyl methylation [22, 32]. This sequence is virus specific and can be
inverted, as exemplified by the vesicular stomatitis virus (VSV), a member of the Rhabdoviri‐
dae family. The VSV also encodes a dual MTase, but the 2’OMTase takes place first and is
followed by the N7MTase [33]. These dual MTases have likely evolved their second MTase
activity out of their initial MTase fold.
3.5. Gene organization of viral capping enzymes
In order to support viral replication and fitness, both the catalytic activity of viral enzymes
involved in RNA capping as well as their localization within the cell, are crucial. Viral capping
enzymes required for RNA capping have to be recruited at the site of RNA synthesis. Recruit‐
ment of the capping enzyme can be mediated by protein-protein interactions with either the
RNA polymerase or a scaffold protein. While recruitment of the three distinct enzymatic
activities is required in order to synthesise a cap-0 structure, the available surface for protein
interactions at the RNA synthesis site is limited. Viruses have evolved multiple solutions to
overcome this problem including the fusion of multiple enzymatic activities to the same
polypeptide as well as protein-protein interactions between two capping enzymes to form a
hetero-multimer (Fig. 6). A good example of protein-protien interaction is seen in Paramecium
bursaria Chlorella virus, which encodes the RTPase, GTase and N7MTase activities on three
different peptides [19, 34, 35]. The RTPase enzyme is likely to interact with the GTase, in a
manner that is reminiscent of the lower eukaryotic capping machinery in which the Pol II co-
transcriptionally recruits the RTPase-GTase heterodimer and the N7MTase separetely [36,
37]. Alternatively, viruses such as Baculovirus and Infectious Spleen and Kidney Necrosis virus
benefit from the fusion of the RTPase and the GTase activities in a single polypeptide, thus
facilitating the recruitment of the capping apparatus to the viral RNA polymerase transcription
site [38, 39]. In this instance, the organization of the viral capping enzymes is most analogous
to that of higher eukaryotes in which the RTPase and GTase enzymes are fused together. In
this case, interaction with the GTase domain is solely responsible for RTPase-GTase recruit‐
ment to the RNA Pol II while the N7MTase is recruited separately [40]. The fusion of sequential
enzymatic activities to the same multi-domain protein appears to be more robust than the
heterodimer formation. Because of this, selective pressures have driven the fusion of the
capping gene in a wide variety of viruses. Alphavirus, for example, encodes a single protein
that is able to add a N7 methylated guanosine to a ppRNA, while the RTPase activity is located
on a different peptide [41]. The flavivirus represent an even more striking example of gene
organization optimization. The RTPase in this group shares a catalytic site with the NTPase/
helicase (also implicated in RNA synthesis) on one protein while the GTase and the dual (N7
and 2'OMTase are fused to the RNA dependent RNA polymerase (RDRP) on a second protein.
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In this example, flavivirus managed to pack, within two polypeptides, six different enzymatic
activities, all of which are involved in RNA synthesis and maturation [21, 22, 32].
Figure 6. Gene organization of the canonical capping enzymes. Schematic representation of the genetic organiza‐
tion of the canonical enzymatic activity required to synthesize a cap-0 structure. Examples of organisms associated
with each gene organization is indicated on the left. The color code is representative of structural and mechanistic
enzymatic conservation and is detailed at the bottom of the figure.
Some viruses have even evolved a highly efficient capping enzyme, fusing together all three
or four enzymatic functions required for cap synthesis into what can be described as an RNA-
capping assembly line. Mimivirus and African swine fever virus encode a large, single protein
inclusively harbouring the RTPase, GTase and N7MTase activities. This allows these viruses
to efficiently modify their RNA to generate a cap-0 structure [7, 42]. The conventional cap
synthesis pathway is a directional succession of enzymatic activities such that
RTPase→GTase→N7MTase. Interestingly, the order of the catalytic domains within the
primary sequence of these triple-activity capping enzymes follows the required capping
activity sequence (NH2-RTPase-GTase-N7MTase-COOH). As a result, they not only co-localize
all capping activity to the RNA 5’-end, but also optimize the progression of the RNA through
the capping activity sequence. Poxvirus, typified by the vaccinia virus (VV), also display a nice
example of a multi-capping enzyme. The VV multi-capping enzyme, D1, possesses all three
RTPase, GTase and N7MTase activities. The first two are constitutive while the N7MTase
requires association with the D12 stimulatory subunit. Together this complex is able to modify
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an RNA 5’-end up to a cap-0 structure. It is also interesting to note that the structure of the D12
stimulatory subunit indicates that it used to be a 2’OMTase but that function is now inactive.
Instead, the 2’OMTase activity is now taken over by the dedicated VP39 2’OMTase [23]. This
raises the possibility of an ancestor poxvirus RNA-capping assembly line composed of a D1-
D12-like complex that could process a 5’-triphosphate RNA into a cap-1 RNA. Such an
enzymatic conveyor can currently be found in mammalian reovirus and bluetongue virus.
These two viruses are members of the segmented dsRNA Reoviridae family and transcribe their
plus-strand messenger RNA within an internal capsid particle containing the RDRP and the
capping apparatus. A single protein packs together all four enzymatic activities required to
synthesize a cap-1 structure (RTPase, GTase, N7MTase and 2’OMTase), although the putative
RTPase activity is yet to be confirmed [43-45]. Once again, these activities are presented into
a directional layout that channels the mRNA through successive enzymatic modifications with
the goal of converting its 5’-triphosphate end into a cap-1 end. Moreover, this RNA capping
assembly line is in direct contact with the polymerase, ensuring optimal recruitment of the
nascent mRNA to the capping apparatus [46]. The λ2 and VP4 capping proteins from reovirus
and bluetongue virus are slightly different in regard to their quaternary structure. Reovirus λ2,
which is overall linearly shaped, associates into a pentamer to form a hollow cylinder with
each active site facing the interior of the cavity, or the turret. This barrel is perpendicular to
the spherical internal capsid particle and creates a channel for the nascent mRNA to exit the
internal capsid particle while undergoing complete type-1 mRNA capping [44]. It is interesting
that a diversity of viruses, ranging from dsDNA virus such as Mimivirus, African swine fever
virus and poxvirus, to segmented dsRNA viruses including members of the Reoviridae family,
have evolved such a complex but highly effective RNA-capping assembly line. The convergent
evolution of these systems highlights the critical importance of proper RNA capping for viral
genome replication and overall viral fitness.
3.6. Unconventional 5’ RNA cap synthesis mechanism evolved by different viruses
The capacity to properly cap RNA confers a distinct advantage to many eukaryotic viruses.
Consequently, the selective pressure to maintain this structure is high, which is reflected by
the degree of conservation among the viral capping proteins. Interestingly, this selective
pressure is not directed toward the capping proteins themselves (RTPase, GTase and
N7MTase), but rather toward their final product, the cap structure. Because of this, many
viruses have evolved diverse biosynthetic strategies, divergent from the canonical
RTPase→GTase→N7MTase pathway, allowing them to synthesize or acquire the final cap
structure. This cap structure is in every aspect identical to the canonically synthesized one;
only the enzymatic pathway varies. Many viruses families include members that use an
unconventional 5’ RNA cap synthesis pathway. As of today, three unconventional 5’ RNA cap
synthesis mechanism have been described.
3.7. The m7GTP RNA capping pathway
The m7GTP RNA capping pathway, also termed the alphavirus-like pathway, is found in a
number of (+)ssRNA viruses of the alphavirus (Semliki Forest virus and Sindbis virus),
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potexvirus (Bamboo mosaic virus), tobamovirus (Tobacco mosaic virus), Togaviridae (Rubella
virus and Chikungunya virus) and Hepeviridae (Hepatitis E virus) families [5, 47]. These viruses
encode unique capping machinery capable of synthesizing a cap-0 structure in three sequential
enzymatic reactions. The initial step is quite similar to the conventional capping mechanism
in which an RTPase (nsP2 protein of Semliki Forest virus for example) hydrolyzes the γ-β-
phosphoanhydride bond at the 5’-end of the RNA yielding a ppRNA [48]. Next a GTP molecule
in methylated in position N7 by an atypical N7MTase (nsP1 protein of Semliki Forest virus for
example). This m7GTP is then recognized as a substrate by an atypical GTase (also nsP1 of
protein of Semliki Forest virus for example). The reaction results in the formation of a charac‐
teristic m7GMP-enzyme covalent complex upon the hydrolysis of a pyrophosphate group. This
m7GMP group is finally transferred onto the 5’-end of the acceptor ppRNA, to yield a typical
m7GpppN cap-0 structure [41, 49-52]. The overall capping reaction is then RTPase→atypical
N7MTase→atypical GTase (Fig. 7). It is worth mentioning, however, that not only the order of
chemical modifications differs, but also the protein mechanisms of action. The atypical
N7MTase has fundamental similarities to the standard N7MTase, including the presence of a
SAM binding domain, but its substrate recognition is vastly different. Atypical N7MTase
proteins are unable to methylate GpppN as the canonical N7MTase does, and instead they
specifically methylate GTP (and GDP to some extent) [51]. The atypical GTases are mechanis‐
tically different from their GTase counterpart in that they lack the KxDG conserved motif and
mediate their m7GMP-enzyme intermediate through a conserved histidine instead of a lysine
[41]. These proteins have no activity with GTP, but specifically require m7GTP to form a
covalently bound enzyme complex. Therefore, the conversion from GTP to m7GTP is necessary
prior to the N7-methyl-gunanylyltransferase activity [49].
Of all known eukaryotes and viruses, the m7GTP RNA capping pathway is only used by
members of the (+)ssRNA viruses, which points toward a eukaryote-independent emergence
of this unconventional cap synthesis mechanism. In addition, the conservation of this capping
pathway throughout distantly related viruses harbouring a broad spectrum of hosts, ranging
from plants to animals, suggests an evolution from a common (+)ssRNA virus ancestor.
3.8. The GDP RNA capping pathway
The GDP RNA capping pathway, also termed the Rhabdoviridae-like pathway, is found in
representatives of many (-)ssRNA viruses of the Rhabdoviridae (vesicular stomatitis virus (VSV)
and Rabies virus), paramyxoviridae (Human respiratory syncytial virus and Measles virus),
Bornaviridae (bornavirus), and Filoviridae (Ebola virus and Marburg virus) families [5, 47]. These
viruses encode unconventional capping machinery that catalyzes the formation of a cap-1
structure. These viruses, exemplified by VSV, encode a large L protein harbouring the RNA
dependent RNA polymerase RDRP activity as well as the RNA capping activity. The latter
requires a sequence of four enzymatic activities that differ from the conventional pathway, in
order to generate a cap-1 structure. First, the NTPase activity is responsible for the hydrolysis
of a GTP molecule into a GDP molecule. Then, an RNA GDP polyribonucleotidyl transferase
(PRNTase) catalyzes a two-step reaction. The L protein hydrolyzes the (alpha-beta) phosphoan‐
hydride bond of the pppRNA triphosphate moiety releasing a molecule of pyrophosphate and
creating a covalent enzyme-pRNA intermediate. The pRNA moiety is then transferred onto the
Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications40
GDP to form a GpppN block RNA. In this case, only the α-phosphate originates from the RNA
whereas both the β and γ-phosphates are contributed by the GDP. Finally, synthesis of the cap-1
structure is completed by two successive methylations; the first being methylation of the first
nucleotide of the 2’OH and the second being methylation of the guanine N7 nitrogen [33, 53-57].
When compared to the canonical capping reaction, this unconventional capping pathway
reverses the phosphate contribution from the GTP and the RNA. The covalent  enzyme-
monophosphate-nucleotide intermediate is formed with the RNA instead of the GTP in an
enzyme-pRNA complex instead of an enzyme-GMP complex. Similarly to the conventional
capping pathway, the diphosphate cosubstrate is pre-emptively hydrolysed from its triphos‐
phate precursor, but this time it is GDP instead of ppRNA that is generated. The PRNTase
mechanism of action is also distinct from the GTase one in that the KxDG motif is replace by an
HR motif and the histidine, not the lysine, is responsible for the enzyme-pRNA phosphoa‐
mide bond [55, 56]. Both the N7 and 2’OMTase activities are also present on the L protein and
share the same SAM binding site. The typical lysine-asparagine-lysine-glutamine tetrad is also
Figure 7. Unconventional 5’ RNA cap synthesis mechanisms. The m7GTP capping pathway involves the hydrolysis of
the RNA γ-phosphate by an RTPase, the methylation of a GTP by a N7MTase and the transfer of this m7GTP onto the
diphosphorylated RNA. The GDP capping pathway is initiated by the hydrolysis of GTP to GDP by an NTPase. A
PRNTase then hydrolyzes the γ-and β-phosphates of the RNA to form a covalent enzyme-pRNA intermediate. The
pRNA is then transferred onto the GDP. Further methylation by the N7MTase and 2’OMTase complete the cap-1 struc‐
ture. The contribution of each substrate to the formation of the final 5’ RNA cap structure is highlighted by a color
code: pppRNA (black), GTP (blue) and SAM (green and red).
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predicted to be at the MTase active site. The 2’O position of the GpppN is methylated prior to
the guanine N7 position, which is the opposite order when compared to most canonical cap-1
methylation events [33, 53]. The overall GDP RNA capping sequence can be summarized as
NTPase→PRNTase→2’OMTase→N7MTase (Fig. 7). It is very likely that an ancestral (+)ssRNA
virus polymerase has evolved a PRNTase activity independently from its eukaryotic host. Both
N7 and 2’OMTase, however, have likely been acquired from a eukaryotic host.
3.9. The RNA cap snatching
Some viruses, unable to synthesize their own cap structures, have evolved a clever way to
acquire this important entity: steeling it from their host. This method of cap acquisition, termed
RNA cap snatching, is used by representatives of the Orthomyxoviridae (e.g. Influenza virus,
Thogoto virus), the Arenaviridae (e.g. Lassa virus, Machupo virus) and the Bunyaviridae
(Hantaan virus, La Crosse virus, Tomato Spotted Wilt virus) families [5, 58]. These (-)ssRNA
viruses acquire their cap structure from their hosts capped mRNA. They bind the cap structure,
cleave the RNA a few nucleotides downstream and finally use this short capped RNA to prime
their RDRP [59]. The Arenaviridae and Bunyaviridae express a large monomeric polymerase
where the Orthomyxoviridae expresses an heterotrimeric polymerase (e.g. PB1, PB2 and PA
protein of influenza virus) harbouring all the activities required for cap snatching. The PB2
protein of the Influenza virus, the most studied cap snatching virus, specifically binds the host
mRNA cap structure. The specificity of the binding is crucial and is mediated by the aromatic
stacking of the methylated gunanine coupled to a base-specific interaction with a conserved
acidic residue [60]. While the mode of cap binding is similar between PB2 and other cap-
binding proteins (e.g. eIF4E, nuclear cap binding complex, Vaccinia VP39) its overall fold is
completely different [60]. Once the host mRNA is bound by the cap-binding PB2, the viral PA
subunit cleaves the mRNA a few nucleotides downstream from the cap structure. The length
of the primer RNA generated is virus-dependent, and typically ranges from 10-13 nucleotides
for Influenza virus, but can be as short as 1-2 nucleotides as is seen in the Thogoto virus [59,
61, 62]. The PA endonuclease domain shares a high homology with the type II restriction
enzyme, including the active site conserved (P)Dxn(D/E)xK signature motif [63]. The PA active
site coordinates two Mn2+ cations and is believed to catalyze endonucleolytic cleavage through
a common two-metal dependent mechanism [61, 64]. The short capped oligomers are next used
by the PB1 RDRP as primer to initiate the transcription of the viral mRNAs [58]. PB1 also
specifically binds the viral RNA (vRNA) 3’ and 5’-end through a ribonucleoprotein 1-like motif
((R/K)G(F/Y)(G/A)(F/Y)Vx(F/Y)) [65]. The vRNA serves as a template for the 3’ elongation of
the cellular 10-13 nucleotide-capped primer. The overall cap snatching process results in the
transcription of a chimeric full-length vRNA with a 5’-extension of 10-13 cellular nucleotides
and a cap-2 structure (Fig. 8). Cap snatching enables viruses to acquire their hosts cap structure,
which not only promotes viral replication but also impairs cellular mRNA translation, as
translation of decapped cellular mRNA is impeded and the mRNA is targeted for degradation.
Another consequence of cap snatching is the dependency on a pool of host mRNA molecules
in order to support viral replication. (-)ssRNA viruses that utilize cap snatching have evolved
ways to maintain the precious pool of eukaryotic mRNA. First, the cap binding and endonu‐
clease activity of the trimeric polymerase are only activated upon vRNA binding, limiting the
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waste (induced by the cleavage and downstream degradation) of mRNA when the vRNA are
not loaded on the RDRP [66]. Secondly, some nucleocapsid proteins, first demonstrated by
Hantavirus, are able to bind and protect capped mRNA from degradation in the processing
bodies (P-bodies) [67]. Thus, converting the P-bodies function from mRNA decapping and
decay into cellular cap storage foci. The cap snatching is only observed in segmented (-)ssRNA
viruses; such a unique molecular mechanism supports the hypothesis of a common (-)ssRNA
virus ancestor of today’s virus, despite their tropism now ranging from plants to animals.
The incredible diversity of RNA capping pathways, protein folding and enzymatic mecha‐
nisms of action that have been evolved by viruses all lead to the synthesis of the same
ubiquitous structure is a testimony to the importance of the cap structure for viral genome
replication and global viral fitness.
Figure 8. RNA cap snatching. The viral polymerase complex is activated upon viral RNA binding (dark blue) and spe‐
cifically binds the cellular mRNA cap structure (red) via its cap binding activity. The endonuclease activity cleaves the
bound cellular mRNA 10-13 nucleotides downstream of the cap structure. This short capped oligomer is then used to
prime the RDRP and initiate genome replication, resulting in a chimeric (red and light blue) RNA copy harbouring the
host cap structure (in this example a cap-2 structure).
4. Viral alternatives to cap structures
Most viruses harbour a cap structure at the 5’-end of their RNA. Mutations preventing the
proper capping of their RNA result in infection or replication deficient viruses. This is a strong
proof of the crucial importance of the cap structure for viral RNA stability and translation. Yet
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not all viruses harbour capped RNA, which raises the question about the mechanism they
evolved to overcome this cap dependency? To answer this query it’s important to ask whether
it is the cap structure itself or its function that is essential. In fact, the cap structure is important
for a number of different cellular processes related to mRNA metabolism. For instance, the cap
structure protects the RNA from 5’→3’ exonucleases, preventing their degradation. The RNA
cap structure also represents a definite molecular structure that is specifically recognized by
the eukaryotic initiation factor 4E (eIF4E), which, together with the scaffold protein eIF4G, the
RNA helicase eIF4A and the ribosome binding protein eIF3, promote RNA translation
initiation. While most viruses use a cap structure to fulfill these important roles, some viruses
have evolved cap-independent strategies to ensure the stability and translation of their RNA.
4.1. Viral proteins as substitutes for the cap structure
Viruses of the Picornaviridae (e.g. Poliovirus, Hepatitis A virus), Potyviridae and Caliciviridae
(e.g. Norwalk virus, Feline calicivirus) families bear a special type of RNA 5’-end modification.
The RNA 5’end of these (+)ssRNA viruses is covalently linked to a viral protein [68]. This viral
genome-linked protein (VPg) is not added to the viral genome upon replication, like a regular
cap structure, but is instead directly used by the RDRP as a primer to initiate RNA polymeri‐
sation. VPg is a representative of the class II nucleic acid-protein complex and does not catalyze
its own covalent complex formation (like GTase or PRNTase could do) [69]. The VPg-RNA
formation is instead catalyzed by a second protein, the viral RDRP, which synthesizes the
primer in a template-dependent matter, resulting in a virus specific initiating primer, VPg-
pUpU for Picornaviridae and VPg-pGpU for Calicivirus [70]. VPg is covalently linked to the first
RNA nucleotide via a phosphodiester bond between the RNA α-phosphate and the tyrosine
hydroxyl group situated in the conserved motif (E/D)EYDE(Y/W/F)[71]. The VPg protein
protects the vRNA 5’-end from the cellular 5’→3’ exounucleases, thus limiting the vRNA
degradation. Furthermore, the VPg is used to initiate the RNA polymerisation instead of being
added once the RNA is synthesised. This prevents the formation of 5’-triphosphate vRNA and
limits the cellular anti-viral response, which will be described later [68]. In addition to their
protective role against RNA degradation, some VPg can fulfill a second important role of the
cap structure, promoting the vRNA translation initiation. This is the case of the Caliciviridae
and Potyviridae 15 kDA VPg that is essential for vRNA translation initiation. This VPg directly
interacts with eIF4E (the cap-binding protein) and the eIF3 complex (the 40S binding complex),
which promotes the assembly of the translation initiation complex to the 5’-end of the vRNA
(Fig. 9) [68, 72-75]. This allows VPg-vRNA to bypass the requirement for a direct eIF4E-cap
interaction in order to initiate translation. This property is not conserved among all VPg, the
Picornaviridae VPg is much smaller (2.5 kDA) and is not involved in the vRNA translation
initiation [68]. These viruses instead rely on a highly structured RNA sequence called an
internal ribosome entry site (IRES) to ensure their translation (this will also be described in
more detail later on). All the (+)ssRNA viruses encoding a VPg benefit from its protective effect
on the viral genome, but the Caliciviridae and Potyviridae VPg have evolved an additional
function, promoting vRNA translation initiation. This VPs is a striking example of a cap
substitute as it fulfills two critical functions of the cap structure, namely ensuring vRNA
stability and promoting translation initiation.
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Figure 9. Mechanisms of viral translation initiation. The cap structure of RNA is specifically recognized by eIF4E,
which recruits the cap-dependent translation initiation complex to the 5’-end of capped RNA. Alternatively, the viral
VPg (covalently linked at the 5’-end of vRNA) can directly recruit eIF4E. The conserved viral RNA structure, located
within the 5’-UTR, can directly promote translation initiation. These internal ribosome entry sites (IRES) are catego‐
rized into four different groups, each able to directly recruit a subset of initiation factors and the 40S ribosomal subu‐
nit in order to initiate translation. Of notice, some mechanisms of initiation require RNA scanning (left panel) by the
initiation complex to reach the ORF while others position the ribosome directly adjacent to the transcription initiation
site (right panel). Abbreviation : Human Immunodeficiency virus (HIV), West Nile virus (WNV), Encephalomyocarditis
virus (ECMV), Hepatitis C virus (HCV) and Cricket paralysis virus (CPV), Open reading frame (ORF).
4.2. Highly structured 5’ RNA structure as an alternative to the cap structure
The ribonucleic acid (RNA) is a macromolecule which, according to the central dogma of
molecular biology, is a transient messenger carrying the genetic information required to pilot
the protein synthesis. In addition to this canonical role, RNA, given its high chemical com‐
plexity, can fulfill additional roles including genome support, ordered three-dimensional
structure and even catalytic activity [76]. Many viruses have exploited this capacity of RNA
to form complex structure in order to promote viral replication. Some viruses, lacking
enzymatic activity to synthesize or acquire a cap structure at the 5’-end of their vRNA, have
instead selected a high-order structural RNA element upstream of their coding region. This
peculiar RNA sequence can fold precisely and repeatedly into a definite three-dimensional
structure. This ordered structure has numerous functions including binding to other macro‐
molecule partners. Those viruses use this cis-acting structure to bind directly or indirectly to
ribosomal components in order to assemble the translation initiation complex at the beginning
of their open reading frame (ORF). This promotes the cap-independent translation of viral
genes. Such RNA structures bypassing the cap-dependency for translation initiation are called
internal ribosome entry site (IRES). Many RNA virus families (e.g. Dicistroviridae, Picornaviri‐
dae and some Flaviviridae) use this structure to promote viral protein production. The diversity
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of viruses that have evolved distinct IRES structures can be divided into four categories that
differ in their structure, length, mechanism of ribosome recruitment and robustness (Fig.9).
The first group of IRES, which is the smallest and simplest, is encoded into the Dicistroviri‐
dae (e.g. Cricket paralysis virus) genome. This IRES consists of a 180 nt structure that is able to
directly bind and recruit the 40S ribosomal subunit to the translation initiation site, and does
not require any initiation factors nor methionyl-tRNA to initiate translation (Fig. 9) [77, 78].
The second group of IRES is similar to the first, but slightly larger with 330 nt. These include
Flaviviridae of the Hepacivirus (e.g. Hepatitis C virus) and Pestivirus (e.g. Classical swine fever
virus) genus. The second group of IRES is also able to directly bind the 40S ribosomal subunit,
but requires the contribution of a limited number of initiation factors (eIF2 and eIF3) together
with the methionyl-tRNA in order to initiate the vRNA translation [77-79]. Of notice, the RNA
helicase eIF4A is not required for initiation of the group 1 or 2 IRES, an advantage that comes
at the expense of a limited RNA unwinding capacity. Therefore the initial coding sequence of
the ORF must be encoded by a non-structured RNA sequence, as an RNA structure will block
translation initiation in the absence of helicase activity [78]. The Picornaviridae family viruses
harbour IRES from the third and fourth groups and are similar in many regards. They are the
largest IRES (450 nt) and the most complex. They do not directly bind the 40S ribosomal subunit
and require canonical eIFs (eIF2, eIF3, eIF4A, eIF4B, eIF4G) together with additional proteins
called IRES trans-activating factors (ITAFs) in order to recruit the ribosome and initiate
translation [80]. The difference between these two groups lies in the positioning of the ribosome
relative to the ORF. Group 3, found in the Aphthovirus (e.g. Foot-and-mouth disease virus) and
Cardiovirus (e.g. Encephalomyocarditis virus) genera, recruits the ribosome at the initiating
AUG codon. Group 4, found in the Enterovirus (e.g. poliovirus) and Hepatovirus (e.g. Hepatitis
A virus) genera, recruits the ribosome upstream from the ORF and requires a scanning or
shunting process to move along the RNA in order to reach the AUG codon and initiate
translation [77, 78]. Of notice, those viral IRES (with the exception the of Hepatitis A virus
IRES) are able to bypass the requirement for eIF4E, one of the limiting components of the cap-
dependent translation initiation complex, to initiate their downstream ORF translation [81].
Encoding an IRES into the viral genome is an efficient mechanism evolved by viruses to fulfill
a critical role of the cap structure, namely the translation initiation. The importance of this
structure is exemplified by its remarkable degree of conservation. The case of the Flaviviridae
family presents an interesting example: the members of the Hepacivirus and Pestivirus genera
share a much closer homology between their IRES region than between their coding region,
while members of the Flavivirus genus, do not have any IRES at all and synthesize a cap
structure through a conventional viral RNA capping mechanism [78]. The emergence of viral
alternatives to overcome the lack of a cap structure is a testimony to the crucial functions of
this small structure for viral genome stability, replication and translation.
5. Recognition of the 5'-ends by the innate immune system
In humans, the RNA cap structure harbors additional methylations at the 2'-O site of the first
and second transcribed nucleotides of the mRNAs [82]. The addition of these supplementary
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ribose methylations occurs via enzymatic activities located in the nucleus and cytoplasm,
respectively [83, 84]. Similarly, many different viruses possess RNA 2'-O-methyltransferases
in order to modify their mRNAs. The role of these methylations has however remained elusive
until recently when it was demonstrated that 2'-O methylation of viral mRNAs enhances
virulence through evasion of intrinsic cellular defense mechanisms [85, 86].
5.1. Innate immune response
Viral infection normally results in the generation of immunological non-self RNA species.
Pattern recognition receptors are a crucial component of innate immunity that are responsible
for the detection of non-self RNAs [87]. Toll-like receptors (TLRs), retinoic acid inducible gene-
I (RIG-I)-like receptors (RLRs) and nucleotide oligomerization domain (Nod)-like receptors
(NLRs) are important pattern recognition receptors that recognize non-self nucleic acids of
pathogens [88-90]. For instance, many TLRs can detect viral nucleic acids that are found in
endosomes following the release of nucleic acids from infected cells [91-95]. This eventually
leads to the activation of subsequent immune reactions. In contrast, RLRs detect viral nucleic
acids in the cytoplasm of the infected cells during the early phase of viral replication [96, 97].
This detection leads to the induction of interferons and inflammatory cytokines which
ultimately block viral replication and promote the activation of antigen-presenting cells in
order to eliminate infected cells [98].
RIG-I, MDA5, and LGP2 are important RLRs that can detect cytoplasmic viral RNAs and
induce the expression of cytokines in order to establish a host antiviral state through the
expression of numerous interferon-stimulated genes (ISGs) [98]. These include the protein
kinase PKR and stress-inducible proteins such as IFIT1 and IFIT2 that can inhibit the protein
synthesis machinery of the host cell [99-101]. What is the exact molecular signature found on
viral RNAs that is detected by RLRs? Previous experiments demonstrated that RIG-I specifi‐
cally recognizes 5'-triphosphate groups that can be found on some viral RNAs [102-104].
Viruses must therefore hide or modify their RNA 5'-ends in order to evade the innate immune
recognition through the addition of an RNA cap structure or through the addition of alternative
5' elements, such as viral proteins linked to the 5'end in order to hide their uncapped ends.
This last strategy is used for instance by poliovirus which encodes a protein, VPg, which is
covalently linked to the 5' end of the plus-strand genomic RNA [105]. Viruses that are unable
to maturate their RNA 5’-end have instead evolved immune-evasion strategies to prevent ISGs
induction. For instance, the Hepacivirus protease inhibits the signal transduction resulting
from RIG-I activation [106, 107].
5.2. Importance of the RNA cap 2'-O-methylation
Recent studies suggest that 2'-O-methylation of viral RNAs can enhance the replication of
viruses through evasion of the innate immune response [85, 86]. For instance, coronaviruses
that lack a functional 2'-O-methyltransferase activity induce a higher expression level of type
I interferon [86]. Moreover, these mutant viruses can replicate efficiently in the absence of some
RLRs such as MDA5 [86]. Similarly, poxvirus and coronavirus mutants that lack 2'-O-meth‐
yltransferase activities show an enhanced sensitivity to IFIT proteins. Therefore, it appears that
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2'-O-methylation of cellular mRNAs has evolved as a molecular signature in order to distin‐
guish between self and non-self RNA during viral infection, and that ribose 2′-O-methylation
in the cap structure of viral RNAs plays an important role in viral escape from innate immune
recognition. Not surprisingly, it has been suggested that the development of pharmacological
strategies that could inhibit viral 2'-O-methyltransferases could represent a novel therapy
against viruses that replicate in the cytoplasm of infected cells [85]. In fact, it was previously
shown that mutations of the 2'-O-methyltransferase catalytic residues can block or attenuate
replication [22, 32] and that viral inhibitors such as sinefungin can inhibit methylation and
suppress the replication of certain viruses, such as West Nile virus, in cell culture [108].
6. Conclusion
This chapter explored the viral diversity of enzymatic activities and mechanistic pathways
converging to the maturation of the 5’ cap on viral RNA. The cap structure provides tremen‐
dous advantages to eukaryotic viruses in terms of vRNA stability, gene translation and
immune evasion. Some viruses have evolved enzymatic mechanisms of action unknown to
the eukaryotic domain in order to synthesize this critical structure. Other viruses have
developed novel cap synthesis mechanisms that generate a 5’ cap structure chemically
identical to their hosts, yet formed by an entirely new process. Finally, particular viruses have
also evolved unique mechanisms to steal or mimic the host cap structure. In conclusion, the
incredible diversity and conservation of the mechanisms evolved by viruses to synthesize,
acquire or mimic the 5’ cap structure is a testimony to the importance of viral RNA capping
for viral replication, fitness and infectivity.
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